The WNBA, which has long positioned itself as an advocate on social justice issues, announced a partnership Tuesday with the first FDA-approved over-the-counter daily birth control pill. The drug, Opill, fits with the league’s stated focus on reproductive health-care advocacy during the 2024 season.
“At the WNBA, we are committed to addressing issues that matter to the players, and expanding access to reproductive healthcare is one of those key issues,” the league’s chief growth officer Colie Edison said in a statement. “It’s great to be working with a partner whose values align and authentically integrates into the health equity work our players are dedicated to.” Read More
n an exclusive interview with NBC Olympics, Katie Ledecky dives deep on her mindset heading…
The US Soccer Federation and the Mexican Football Federation have withdrawn their joint bid to…
United States women's national team legend Carli Lloyd announced she is pregnant with her first…
Ondine Achampong says she tore her ACL during a bars dismount. The surgery and recovery…
Parker’s retirement, Moore’s Hall of Fame induction are opportunities to celebrate the game changers
Candace Parker was one of the biggest names in basketball for two decades, and her…